Skip to content
healthcare.dev
Get a free key

Agrylin

NDC 54092-063, anagrelide hydrochloride, capsule, from Takeda Pharmaceuticals America, Inc..

Product NDC
54092-063
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020333
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54092-063 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANAGRELIDE HYDROCHLORIDE ANHYDROUS.5 mg/1

Pharmacologic classes

Decreased Platelet Production [PE]; Phosphodiesterase 3 Inhibitors [MoA]; Platelet-reducing Agent [EPC]

Package NDCNDC-11Package
54092-063-0154092006301100 CAPSULE in 1 BOTTLE (54092-063-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cb960074-99c1-4a73-941f-f0644a7ec219

Use it

Look up 54092-063 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54092-063 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54092-063. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.